findmyKOL

Aminah Jatoi, MD

Enriched profile

Betty J. Foust, M.D. and Parents' Professor of Oncology, Mayo Clinic College of Medicine and Science · Mayo Clinic

ORCIDNPI
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyMedical OncologyFocusGastroesophageal Cancer+5
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2000–2025

Aminah Jatoi is Betty J. Foust, M.D. and Parents' Professor of Oncology, Mayo Clinic College of Medicine and Science at Mayo Clinic. OpenAlex indexes 604 publications with 23,018 citations (h-index 61); ClinicalTrials.gov lists 42 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Aminah Jatoi, MD, is Betty J. Foust, M.D. and Parents' Professor of Oncology, Mayo Clinic College of Medicine and Science. The public record shows 604 publications with 23,018 citations (h-index 61), centered on Gastroesophageal Cancer, Breast Cancer, Lung Cancer (NSCLC/SCLC). It also documents an investigator role on 42 registered clinical trials, industry payments reported by 2 companies, 13 NIH-funded awards (2000–2025).

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Gastroesophageal Cancer
  • 42 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Gastroesophageal Cancer8 trialsEsophageal Neoplasms8 trialsPain8 trialsLung Cancer (NSCLC/SCLC)7 trialsAnorexia6 trialsStomach Neoplasms4 trialsCachexia4 trialsProstate Cancer2 trialsAdenocarcinoma of Lung1 trialCarcinoma, Small Cell1 trialDepression (MDD)1 trialDelirium1 trialBreast Cancer1 trialHead & Neck Cancer1 trialDysgeusia1 trialFatigue1 trialFallopian Tube Neoplasms1 trialCarcinoma, Ovarian Epithelial1 trialSpasm1 trialHiccup1 trialPancreatic Cancer1 trialIBS / Functional GI1 trialConstipation1 trial

Research focus

OpenAlex concept fingerprint
Gastroesophageal CancerBreast CancerLung Cancer (NSCLC/SCLC)Head & Neck CancerPancreatic CancerProstate Cancer

Works with

trial sponsors and companies reporting payments
Alliance for Clinical Trials in OncologyClinical trials25Industry paymentsMayo ClinicClinical trials15Industry paymentsPfizer Inc.Clinical trialsIndustry payments7

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
604publications

Distinct works indexed by OpenAlex, matched via ORCID; 57 in PubMed.

23,018citations

Total citations across indexed works.

61h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
42clinical trials

Investigator role on registered studies.

View trials
2companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
13NIH grants · 2000–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 42 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

2 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    53.4%
    Serotonin-3 Receptor Antagonist53.4%
    Palonosetron hcl59%Ondansetron hydrochloride37%Ondansetron Hcl5%
    Part D + Part B19 patients
  • Sensory organs

    40.2%
    Corticosteroid40.2%
    Dexamethasone sodium phosphate91%Dexamethasone9%
    Part D + Part B<11 patients
  • Nervous system

    6.4%
    Phenothiazine3.4%
    Prochlorperazine Maleate100%
    Part D16 patients
    Atypical Antipsychotic3%
    Olanzapine100%
    Part D14 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

13 NIH research awards on record, funded 20002025 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/aminah-jatoi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/scientific-contributions/Aminah-Jatoi-38170856

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    mcpress.mayoclinic.org/rise-for-equity/rise-for-equity-women-in-medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcpress.mayoclinic.org
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director

    Paul Calabresi Program in Clinical-Translational Research, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org
  • Editorial board member

    Journal of Clinical Oncology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org
8 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Contributor/editor

    ESMO Handbook of Nutrition and Cancer (2nd Edition), European Society for Medical Oncology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncologypro.esmo.org

Media & interviews

press, podcasts and appearances
  • Guest

    "RISE for Equity: Women in Medicine" podcast, Mayo Clinic Press (with Dr. Yemi Sokumbi, hosted by Nicole Nfonoyim-Hara)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcpress.mayoclinic.org

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.